| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 22.36B | 23.35B | 22.13B | 22.31B | 21.32B | 20.52B |
| Gross Profit | 4.80B | 5.27B | 4.35B | 4.17B | 3.66B | 3.30B |
| EBITDA | 4.36B | 4.65B | 4.21B | 4.14B | 3.72B | 3.42B |
| Net Income | 1.19B | 1.46B | 1.15B | 1.02B | 676.00M | 519.00M |
Balance Sheet | ||||||
| Total Assets | 89.79B | 93.49B | 90.86B | 90.64B | 91.09B | 92.60B |
| Cash, Cash Equivalents and Short-Term Investments | 1.48B | 1.32B | 1.05B | 1.47B | 1.44B | 1.26B |
| Total Debt | 54.66B | 53.90B | 55.73B | 56.25B | 58.74B | 60.66B |
| Total Liabilities | 65.82B | 68.20B | 67.32B | 67.69B | 69.85B | 71.97B |
| Stockholders Equity | 23.96B | 25.29B | 23.54B | 22.94B | 21.24B | 20.63B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -153.00M | 355.00M | 1.93B | 1.65B | 1.08B |
| Operating Cash Flow | 0.00 | 3.84B | 2.96B | 3.78B | 3.42B | 2.81B |
| Investing Cash Flow | 0.00 | -2.39B | -2.02B | -1.32B | -1.35B | -1.07B |
| Financing Cash Flow | 0.00 | -1.18B | -1.36B | -2.44B | -1.89B | -1.84B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥14.49B | 8.51 | ― | 0.26% | 2.92% | 5.59% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥313.65B | 13.49 | ― | 1.61% | 1.51% | 14.84% | |
60 Neutral | ¥42.42B | 11.08 | ― | 2.17% | 4.27% | 33.45% | |
58 Neutral | ¥220.46B | 7.11 | 12.70% | 1.68% | 6.91% | 58.68% | |
54 Neutral | ¥19.31B | 13.17 | ― | 0.81% | 5.49% | 29.14% | |
50 Neutral | ¥18.43B | 16.20 | ― | 1.33% | 11.16% | -16.05% |